MedAssets (MDAS) Tops Q2 EPS by 4c; Guides FY15 EPS Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
KeyBanc Downgrades MedAssets (MDAS) to Sector Weight
July 31, 2015 7:29 AM EDTKeyBanc downgraded MedAssets (NASDAQ: MDAS) from Overweight to Sector Weight.
Analyst Donald Hooker said, "We are downgrading MedAssets, Inc. (MDAS) to Sector Weight on the recent share price increase (last 6 months: up 26% vs. S&P up 5%). We think the shares are getting a healthy... More
Leerink Raises Price Target on MedAssets (MDAS) Following 2Q EPS Beat
July 30, 2015 10:32 AM EDTLeerink Partners reiterated a Market Perform rating on MedAssets (NASDAQ: MDAS), and raised the price target to $22.00 (from $21.00), following 2Q15 results. MDAS reported 2Q total revenue of $190.4M, ahead consensus of $187.3M. Adjusted EPS of $0.31 was also ahead of consensus of $0.27.
Analyst David Larsen commented, "This afternoon... More
